Trial protocol (no results yet): a randomised, double-blind trial will enrol 124 patients with stage II–IV or platinum-sensitive recurrent high-grade ovarian cancer on platinum chemotherapy to a 5-strain probiotic (WBF-038) or placebo; primary endpoint is gut microbiome change.
RCTn = 124
Chambers et al. PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy